Andrew Faughnan | executive |
Bradley Campbell | executive |
Sebastien Martel | executive |
Jeffrey Castelli | executive |
Simon Nicolas Harford | executive |
Tazeen Ahmad | analyst |
Anupam Rama | analyst |
Ritu Baral | analyst |
Mike Keavany | executive |
Joseph Schwartz | analyst |
Eliana Merle | analyst |
Kristen Kluska | analyst |
Dae Gon Ha | analyst |
Gil Blum | analyst |
Lee Hung | analyst |
Salveen Richter | analyst |
Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics Third Quarter 2023 Financial Results Conference Call and Webcast. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mr.